Summary:
A Russian company from the Rostov region is developing a serial implantation device to solve the problem of erectile dysfunction with minimal invasion. The Russian company is looking for foreign partners to conclude a distribution services agreement. The partner should help the Russian company in facilitating the receipt of European certification.
Description:
The Russian company from the Rostov region was founded in 2020. This is a young innovative company that develops medical implants.
The Russian company is engaged in the development and production of a remedy that preserves more than 80% of marriages ready to break up before (proven on 2500 patients). This tool works by raising the degree of satisfaction of partners. According to researchers, the satisfaction of partners is more than 90%. The Russian company produces an implant in the cavernous bodies, which completely relieves the patient from erectile dysfunction and allows the patient to perform introjections and frictions at any time, at any age and without limitation of duration.
The company also creates the world's first two-component controlled implant in the cavernous bodies with the function of changing the diametrical size to solve the problem of erectile dysfunction. This implant is suitable for age-related and age-related diseases, neurogenic disorders at the level of the brain and spinal cord, endocrine diseases, including diabetes mellitus, diseases of the cardiovascular system (hypertension, atherosclerosis), diseases of the genitourinary system, etc. The implant has a lifetime warranty. According to Russian scientists, the probability of complications when installing an implant is several times lower than when installing the best imported analogues. The two - component implant under development works as a three-component one in terms of its functions and a set of characteristics and has all its advantages over one-and two-component ones, including the possibility of safe and planned switching on and off.
The Russian company is looking for foreign partners from the medical field, scientific institutes, clinics to conclude a distribution services agreement. In accordance with this agreement, the Russian company will supply its products. The partner, in turn, will have to distribute medical implants. The partner will also have to assist in obtaining an additional EU and other certificate on an equal basis with the Russian company.
The purpose of this agreement is to increase profits, exports and find new foreign partners.
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought:
Type: SMEs, large companies, medical companies, scientific institutes in the field of medicine, development of medical implants.
Role: In accordance with this agreement, a potential partner will have to deal with distribution in its market. In addition, it is assumed that the partner will undertake obligations to obtain EU certification for implants.
Stage of Development:
Already on the market
IPR Status:
Secret Know-how
External code:
BORU20210719001
